Update on prostate cancer in black men

Journal of Men's Health and Gender

Volumn 4, Issue 4, 2007, Pages 456-463

  Salami, Mudashiru A ^a   Etukakpan, Blessing ^a   Olapade Olaopa, E Oluwabunmi ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Black men; Cancer; Carcinoma of the prostate (CaP); Epidemiology; Ethnicity; Prostate

Indexed keywords

ANDROGEN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER SCREENING; ETHNICITY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEALTH CARE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE;

EID: 36549034243     PISSN: 15718913     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhg.2007.07.041     Document Type: Article

References (79)

1. Litwin MS, Saigal CS, editors. Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 07-5512. Washington, DC: US Government Printing Office; 2007.
2. Osegbe D.N. Prostate cancer in Nigerians; facts and nonfacts. J Urol 157 (1997) 1340-1343
3. Crawford E.D. Epidemiology of prostate cancer. Urology 62 Suppl (2003) 3-12
4. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, et al. The risk of prostate cancer amongst black men in the United Kingdom: The PROCESS Cohort Study. Eur Urol 2007 [in press] PMID: 17368710.
5. Glover Jr. F.E., Coffey D.S., Douglas L.L., Cadogan M., Russell H., Tulloch T., et al. The epidemiology of prostate cancer in Jamaica. J Urol 159 (1998) 1984-1986
6. Thompson I., Tangen C., Tolcher A., Crawford E., Eisenberger M., and Moinpour C. Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Natl Cancer Inst 93 (2001) 219-225
7. Gueye S.M., Zeigler-Johnson C.M., Friebel T., Spangler E., Jalloh M., MacBride S., et al. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology 61 (2003) 987-992
8. Powell I.J., Banerjee M., Sakr W., Grignon D., Wood Jr. D.P., Novallo M., et al. Should African-American men be tested for prostate carcinoma at an earlier age than white men?. Cancer 85 (1999) 472-477
9. Powell I.J. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 177 (2007) 444-449
10. American Cancer Society. Cancer Facts and Figures, 2004. Atlanta, GA: American Cancer Society. Available at: http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf.
11. Ries LAG, Elsner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al, editors. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003. Available at: http://seer.cancer.gov/csr/:1975-2000/.
12. Glover Jr. F.E., Coffey D.S., Douglas L.L., Russell H., Cadigan M., Tulloch T., et al. Familial study of prostate cancer in Jamaica. Urology 52 (1998) 441-443
13. Heyns C.F., Naude A.M., Visser A.J., Marais D.C., Stopforth H.B., Nyarko J.K., et al. Early diagnosis of prostate cancer in the Western Cape. S Afr Med J 91 (2001) 679-684
14. Shimizu H., Ross R.K., Bernstein L., Yatani R., Henderson B.E., and Mack T.M. Cancer of the prostate and breast among Japanese and white immigrants in Los Angeles country. Br J Cancer 63 (1991) 963-966
15. Edwards A., Hammond H.A., Jin L., Caskey C.T., and Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human populations. Genomics 12 (1992) 241-253
16. Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Dahl D., Brufsky A., et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94 (1997) 3320-3323
17. Platz E.A., Rimm E.B., Willett W.C., Kantoff P.W., and Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system among male health professionals. J Natl Cancer Inst 92 (2000) 2009-2017
18. Panz V., Joffe B., Spitz I., Lindenberg T., Farkas A., and Haffejee M. Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men. Endocrine 15 (2001) 213-216
19. Sartor O., Zheng Q., and Eastham J.A. Androgen receptor gene CAG repeat length varies in race-specific fashion in men without prostate cancer. Urology 53 (1999) 378-380
20. Linja M.J., Savinainen K.J., Saramaki O.R., Tammela T.L., Vessella R.L., and Visakorpi T. Amplification and over expression of androgen receptor gene in hormone refractory cancer. Cancer Res 61 (2001) 3550-3555
21. Lord O., Gregorry C., Kim D., Smitherman A., and Mohler J. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. J Urol 170 (2003) 1817-1821
22. Gaston K.E., Kim D., Singh S., Ford III O.H., and Mohler J.L. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 170 (2003) 990-993
23. Olapade-Olaopa E.O., Muronda C.A., Mackay E.H., Danso A.P., Sandhu D.P., Terry T.R., et al. Androgen receptor protein expression in prostate tissues in black and Caucasian men. Prostate 59 (2004) 460-468
24. Henshall S.M., Quinn D.I., Lee C.S., Head D.R., Golovsky D., Brenner P.C., et al. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res 61 (2001) 423-437
25. Ellis L., and Nyborg H. Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steriods 57 (1992) 72-75
26. Ross R.K., Bernstein L., Lobo R.A., Shimizu H., Stanczyk F.Z., Pike M.C., et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339 (1992) 887-889
27. Henderson B.E., Bernstein L., Ross R.K., Depue R.H., and Judd H.L. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 57 (1988) 216-218
28. Makridakis N.M., Ross R.K., Pike M.C., Crocitto L.E., Kolonel L.N., Pearce C.L., et al. Association of missense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men Los Angeles, USA. Lancet 354 (1999) 975-978
29. Ando Y., Tateishi T., Sekido Y., Yamamoto T., Satoh T., Hasegawa Y., et al. Modification of clinical presentation of prostate tumours by a novel genetic variant in CYP3A4. J Natl Cancer Inst 91 (1999) 1587-1590
30. Bangsi D., Zhou J., Sun Y., Patel N.P., Darga L.L., Heilbrun L.K., et al. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Urol Oncol 24 (2006) 21-27
31. Kittles R.A., Baffoe-Bonnie A.B., Moses T.Y., Robbins C.M., Ahaghotu C., Huusko P., et al. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African-American men with a positive family history. J Med Genet 43 (2006) 507-511
32. Lin W., Innocenti F., Chen P., Das S., Cook J.E., and Ratain M. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intro 1 polymorphism. Clin Cancer Res 9 (2003) 1009-1012
33. Shuch B., Mikhail M., Satagopan J., Lee P., Yee H., Chang C., et al. Racial disparity of epidermal growth factor receptor expression in prostatic disease. J Clin Oncol 22 (2004) 4725-4729
34. Olapade-Olaopa E.O., Moscatello D.K., MacKay E.H., Ogunbiyi J.O., Shittu O.B., Terry T.R., et al. A variant epidermal growth factor receptor protein is similarly expressed in benign hyperplastic and carcinomatous prostatic tissues in black and white men. West Afr J Med 26 (2007) 42-47
35. Moscatello D.K., Holgado-Madruga M., Godwin A.K., Ramirez G., Gunn G., Zoltick P.W., et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumours. Cancer Res 55 (1995) 5536-5539
36. Tukeri L., Sakr W., Wykes S., Grigon D., Pontes J., and Macoska J. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign and malignant prostate tissue. Prostate 25 (1994) 199-205
37. Olapade-Olaopa E.O. The expression of a mutant epidermal growth factor receptor in prostatic tumours. British Journal of Cancer 87 (2001) 224-226
38. Hermes E., Fossa S., Berner A., Otnes B., and Nesland J. Expression of the epidermal growth factor receptor family in prostatic carcinoma before and during androgen-independence. Br J Cancer 26 (2004) 449-454
39. Lorimer I. Mutant epidermal growth factor receptors as targets for cancer therapy. Curr Cancer Drug Targets 2 (2002) 91-102
40. Modjtahedi H., Moscatello D., Box G., Green M., Shotton C., Lamb D., et al. Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy. Int J Cancer 105 (2003) 273-280
41. Jackson M., Ahluwalia B., Attah E., Conolly C., Herson J., Heshmat M., et al. Characterization of prostatic carcinoma among blacks: a preliminary report. Cancer Chemother Rep 59 (1975) 3-15
42. Jackson M., Ahluwalia B., Attah E., Herson J., Heshmat M., Jackson A., et al. Characterization of prostatic carcinoma among blacks: a continuation report. Cancer Treat Rep 51 (1977) 167-172
43. Sakr W.A., Grignon D.J., Haas G.P., Schomer K.L., Heilbrun L.K., Cassin B.J., et al. Epidemiology of high grade prostate intraepithelial neoplasia. Pathol Res Pract 191 (1995) 838-841
44. Whittemore A.S., Keller J.P., and Botenskcy R. Low grade; latent prostate cancer volume: Predictor of clinical cancer evidence?. J Natl Cancer Inst 83 (1991) 1231-1235
45. Fowler J.E., and Bigler S.A. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostatic carcinoma. Cancer 86 (1999) 836-841
46. Ukoli F., Osime U., Akereyeni F., Okunzuwa O., Kittles R., and Adams-Campbell L. Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Int J Urol 10 (2003) 315-322
47. Jani A.B., Vaida F., Hanks G., Asbell S., Sartor O., Moul J.W., et al. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int J Cancer 96 (2001) 363-371
48. Abbiyesuku F., Shittu O., Oduwole O., and Osotimehin B. Prostate specific antigen in the Nigerian African. Afr J Med Med Sci 29 (2000) 97-100
49. Heyns C., Mathee S., Isaacs A., Kharwa A., Beer P.D., and Pretorius M. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa. BJU Int 91 (2003) 785-788
50. Yanke B., Carver B., Bianco F., Simoneaux W., Venable D., Powell I., et al. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int 98 (2006) 783-787
51. Shelton P., Weinrich S., and Reynolds W. Barriers to prostate cancer screening in African American men. J Nat Black Nurses Assoc 10 (1999) 14-28
52. Weinrich S., Boyd M., Bradford D., Mossa M., and Weinrich M. Recruitment of African Americans into prostate cancer screening. Cancer Pract 6 (1998) 23-30
53. Powell I., Heilburn L., Littrup P., Franklin A., Parzuchowski J., Gelfand D., et al. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J Urol 158 (1997) 146-149
54. Woods V., Montgomery S., and Herring R. Recruiting Black/African American men for research on prostate cancer prevention. Cancer 100 (2004) 1017-1025
55. Merrill R.M., and Lyon J.L. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 55 (2000) 730-735
56. Powell I.J., Heilbrun L.K., Sakr W., Grignon D., Montie J., Novallo M., et al. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of surgical margins. Urology 49 (1997) 726-731
57. Pettaway C.A., Troncoso P., Ramirez E.I., Johnston D.A., Steelhammer L., and Babaian R.J. Specific antigen and pathological features of prostate cancer in black and white patients. A comparative study based on radical prostatectomy specimens. J Urol 166 (1998) 437-442
58. Powell I.J., Dey J., Dudley A., Pontes J.E., Cher M.L., Sakr W., et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology 59 (2002) 907-912
59. Grossfeld G.D., Latini D.M., Downs T., Lubeck D.P., Mehta S.S., and Carroll P.R. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol 168 (2002) 2510-2515
60. Powell I.J., Banerjee M., Novallo M., Sakr W., Grignon D., Wood D.P., et al. Prostate cancer biochemical recurrence stage is more frequent among African-American than white men with locally advanced but not organ-confined diseases. Urology 55 (2000) 246-251
61. Wang Y., Corr J.G., Thaler H.T., Tao Y., Fair W.R., and Heston W.D. Decreased growth of established human prostate LNCaP tumors in nude mice fed on a low fat diet. J Natl Cancer Inst 87 (1995) 1456-1462
62. Whittemore A.S., Kolonel L.N., Wu A.H., John E.M., Gallagher R.P., Howe G.R., et al. Prostate cancer in relation to diet, physical activity and body size in blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst 87 (1995) 652-661
63. Amling C.L., Riffenburgh R.H., Sun L., Moul J.W., Lance R.S., Kusuda L., et al. Pathologic variable and recurrence rates as related to obesity and in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
64. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94 (2002) 334-357
65. Underwood III W., Wei J., Rubin M.A., Montie J.E., Resh J., and Sunda M.G. Postprostatectomy cancer-free survival of African-Americans is similar to non-African-Americans after adjustment for baseline cancer severity. Urol Oncol 22 (2004) 20-24
66. Powell I.J., Banerjee M., Bianco F.J., Wood D.P.J., Dey J., Lai Z., et al. The effect of race/ethnicity on prostate cancer treatment outcome is conditional: a review of Wayne University data. J Urol 171 (2004) 1508-1512
67. Shavers V.L., Brown M.L., Potosky A.L., Klabunde C.N., Davis W.W., Moul J.W., et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Int Med 19 (2004) 145-155
68. Etzioni R., Berry K.M., Legler J.M., and Shaw P. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. Urology 59 (2002) 251-255
69. Hoffman R.M., Harlan L.C., Klabunde C.N., Gilliland F.D., Stephenson R.A., Hunt W.C., et al. Racial differences in initial treatment for clinically localized prostate cancer. Result from the prostate outcomes study. J Gen Int Med 18 (2003) 845-853
70. O'Dell K., Volk R., and Cass A. Screening for prostate cancer with PSA: are patients making informed decisions?. J Fam Pract 48 (1999) 679-681
71. Myers R., Wolf T., Ralshem A., Ross E., and Chodak G. Receptivity of African-American men to prostate cancer screening. Urology 43 (1994) 480-487
72. Clarke-Tasker V., and Wade R. What we thought we knew: African American males' perceptions of prostate cancer and screening methods. ABNF J 13 (2002) 56-60
73. Abbott R.R., Taylor D.K., and Barber K. A comparison of prostate knowledge of African-American and Caucasian men: changes from prescreening baseline to post intervention. Cancer J Sci Am 4 (1998) 175-177
74. Olapade-Olaopa EO, Owoaje ET, Ladipo MM, Adebusoye A, Muoka OE, Gopaldasani VI. Knowledge and awareness of prostate cancer in men aged 40 years and above in Ibadan, Southwestern Nigeria. Presented at the World Cancer Congress, Washington DC, July 2006.
75. Agho A.O., and Lewis M.A. Correlates of actual and perceived knowledge of prostate cancer among African Americans. Cancer Nurs 24 (2001) 165-171
76. Magnus M. Prostate cancer knowledge among multiethnic black men. J Natl Cancer Inst 96 (2004) 650-656
77. Smith G.E., DeHaven M.J., Grundig J.P., and Wilson G.R. African-American males and prostate cancer: assessing knowledge levels in the community. J Nat Med Assoc 89 (1997) 387-391
78. Wilkinson S., List M., Sinner M., Dai L., and Chodak G. Educating African American men about prostate cancer: impact on awareness and knowledge. Urology 61 (2003) 308-313
79. Olapade-Olaopa EO, Muoka OE, Owoaje ET, Ladipo MM, Gopaldasani VI. Impact of a health education intervention on cancer of the prostate awareness amongst Nigerian men. Presented at the World Cancer Congress, Washington DC, July 2006.